According to a recent study conducted by PhytoVista and commissioned by UK’s Centre for Medical Cannabis (CMC), the THC levels were exceeded in almost half of 30 CBD products currently being sold in the UK. While the accepted level of the psychoactive THC is 0,2%, in many cases it was exceeded almost twofold.
In addition to this, the researchers have come across other problems, such as:
• Only 11 of 29 products tested were within 10% of the advertised CBD content.
• 11 of 29 products had less than 50% of the advertised CBD content.
• One product had 3.8% ethanol, more than the 3.4% that defines alcoholic beverages in the UK.
These findings mirror the results of a similar study conducted in the US as early as in the year 2017 and are calling for clear guidance and regulation of the hemp extracts market.
In fact, the findings prompted the UK’s Royal Pharmaceutical Society (RPS) to issue a call to the government for “clear guidance on the permissible level of psychoactive tetrahydrocannabinol (THC) in cannabidiol (CBD) oils.”
The sheer scale of the problem also highlights the importance of buying only certified CBD products from trusted, well-established providers.